Cargando…
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Alternative splicing, a fundamental step in gene expression, is deregulated in many diseases. Splicing factors (SFs), which regulate this process, are up- or down regulated or mutated in several diseases including cancer. To date, there are no inhibitors that directly inhibit the activity of SFs. We...
Autores principales: | Denichenko, Polina, Mogilevsky, Maxim, Cléry, Antoine, Welte, Thomas, Biran, Jakob, Shimshon, Odelia, Barnabas, Georgina D., Danan-Gotthold, Miri, Kumar, Saran, Yavin, Eylon, Levanon, Erez Y., Allain, Frédéric H., Geiger, Tamar, Levkowitz, Gil, Karni, Rotem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453957/ https://www.ncbi.nlm.nih.gov/pubmed/30962446 http://dx.doi.org/10.1038/s41467-019-09523-0 |
Ejemplares similares
-
Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
por: Mogilevsky, Maxim, et al.
Publicado: (2018) -
Identification of recurrent regulated alternative splicing events across human solid tumors
por: Danan-Gotthold, Miri, et al.
Publicado: (2015) -
Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017) -
Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells
por: Danan-Gotthold, Miri, et al.
Publicado: (2016) -
Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer
por: Canello, Tamar, et al.
Publicado: (2014)